Allogene Therapeutics
ALLO
ALLO
94 hedge funds and large institutions have $1.85B invested in Allogene Therapeutics in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 13 closing their positions.
Holders
94
Holders Change
+8
Holders Change %
+9.3%
% of All Funds
2.04%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
25
Increased
38
Reduced
20
Closed
13
Calls
$2.94M
Puts
$2.34M
Net Calls
+$599K
Net Calls Change
+$1.26M
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
RJA
101
Raymond James & Associates
St Petersburg,
Florida
| – | – | -42,000 | Closed |
|
102
Arrowstreet Capital
Boston,
Massachusetts
| – | – | -28,500 | Closed |
|
|
SO
103
STRS Ohio
Columbus,
Ohio
| – | – | -5,800 | Closed |
|
|
FAM
104
Fred Alger Management
New York
| – | – | -5,000 | Closed |
|
|
CCA
105
Catalyst Capital Advisors
Huntington,
New York
| – | – | -179 | Closed |
|
106
Bessemer Group
Woodbridge,
New Jersey
| – | – | -130 | Closed |
|
|
PCP
107
Proficio Capital Partners
Newton,
Massachusetts
| – | – | -15 | Closed |
|
108
Walleye Capital
New York
| – | – | – | – |
|
|
CFGS
109
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
110
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
CG
111
Cutler Group
San Francisco,
California
| – | – | – | – |
|